To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese

Clinical trial NCT06396429 · COMPLETED

Trial details

NCT number: NCT06396429
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2024-05-13
Primary completion: 2025-07-07
Enrollment: 567

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.